Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.
about
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case reviewAge-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.Peer-reviewed publication of clinical trials completed for pediatric exclusivityDrug labeling and exposure in neonatesPharmacokinetic optimization of antiretroviral therapy in children and adolescents.Pharmacokinetic considerations in the use of antivirals in neonates.
P2860
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@ast
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@en
type
label
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@ast
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@en
prefLabel
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@ast
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@en
P2093
P2860
P1476
Pharmacokinetics of stavudine ...... ciency virus-exposed neonates.
@en
P2093
A Srigritsanapol
C Rongkavilit
D A Cooper
E A Hassink
K Ruxrungtham
P Phanuphak
P Thaithumyanon
P2860
P304
P356
10.1128/AAC.45.12.3585-3590.2001
P407
P577
2001-12-01T00:00:00Z